Intrinsiqq
The Oncology Institute Inc. logo

The Oncology Institute Inc. (TOI) Insider Trading

Last 12 months

Insiders sold $2.81M and bought nothing on the open market.

91% of the selling was scheduled in advance under 10b5-1 plans. Director Mark L Pacala sold $200k on Nov 18, 2025, 22% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2025.

Net open-market
−$2.81M
0 buys · 6 sales
Under a 10b5-1 plan
91%
of the value sold
Insiders who bought / sold
0 / 4
executives and directors
Last open-market buy
Mar 2025
Mar 26, 2025

Get an email when TOI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 2110b5-1 plan
    Brad Hively
    Director · sold 298,853 at $6.51
    $1.95M
    42% of stake
  • Aug 14
    Jorey Chernett
    Large holder · bought 12,000 at $6.54
    $78k
    0.1% of stake
  • Jul 21
    Jorey Chernett
    Large holder · bought 18,000 at $5.27
    $95k
    0.2% of stake
  • Jul 1410b5-1 plan
    Yale Podnos
    Chief Medical Officer · sold 23,452 at avg $6.41
    $150k
    8.3% of stake
  • Jul 10
    Jorey Chernett
    Large holder · bought 15,000 at $5.85
    $88k
    0.1% of stake
  • Jun 23
    Jorey Chernett
    Large holder · bought 18,000 at $5.02
    $90k
    0.2% of stake
  • Jun 810b5-1 plan
    Yale Podnos
    Chief Medical Officer · sold 23,451 at $5.38
    $126k
    8.3% of stake
  • Jun 4
    Jorey Chernett
    Large holder · bought 12,000 at $4.75
    $57k
    0.1% of stake
  • May 19 – 20
    Jorey Chernett
    Large holder · bought 38,500 at avg $4.07
    $157k
    0.4% of stake
  • May 19
    Jorey Chernett
    Large holder · bought 30,000 at $4.09
    $123k
    0.3% of stake
  • Apr 14 – 1610b5-1 plan
    Mohit Kaushal
    Director · sold 95,719 at avg $3.50
    $335k
    36% of stake
  • Apr 9
    Jorey Chernett
    Large holder · bought 20,000 at $3.10
    $62k
    0.2% of stake
  • Mar 27
    Jorey Chernett
    Large holder · bought 27,429 at $2.96
    $81k
    0.3% of stake
  • Mar 26
    Jorey Chernett
    Large holder · bought 50,000 at $3.15
    $158k
    0.5% of stake
  • Mar 24
    Jorey Chernett
    Large holder · bought 125,000 at $3.11
    $389k
    1.2% of stake
  • Mar 20
    Jorey Chernett
    Large holder · bought 25,000 at $3.35
    $84k
    0.2% of stake
  • Mar 13 – 17
    Jorey Chernett
    Large holder · bought 398,985 at avg $3.07
    $1.23M
    4.0% of stake
  • Dec 15, 2025No plan
    Brad Hively
    Director · sold 13,333 at $3.77
    $50k
    1.9% of stake
  • Nov 18, 2025No plan
    Mark L Pacala
    Director · sold 50,000 at avg $4.00
    $200k
    22% of stake
  • Sep 4, 2025No plan
    M33 Growth I GP LLC
    Large holder · sold 6,700,000 at avg $3.09
    $20.7M
    44% of stake
  • Aug 19, 2025No plan
    Brad Hively
    Director · sold 20,221 at $4.06
    $82k
    3.1% of stake
  • Jun 5, 2025No plan
    M33 Growth I GP LLC
    Large holder · sold 750,000 at avg $3.05
    $2.29M
    4.7% of stake
  • Jun 3, 2025No plan
    Brad Hively
    Director · sold 1,976,137 at avg $2.87
    $5.67M
    77% of stake
  • May 20, 2025No plan
    M33 Growth I GP LLC
    Large holder · sold 2,000,000 at avg $2.71
    $5.42M
    11% of stake
  • Mar 26, 2025
    Brad Hively
    Director · bought 45,280 at $1.04
    $47k
    6.8% of stake
  • Mar 26, 2025
    Daniel Virnich
    Chief Executive Officer · bought 22,640 at $1.04
    $24k
    3.2% of stake
  • Mar 26, 2025
    Yale Podnos
    Chief Medical Officer · bought 9,056 at $1.04
    $9k
    13% of stake
  • Mar 26, 2025
    Mark L Pacala
    Director · bought 90,562 at $1.04
    $94k
    67% of stake
  • Mar 26, 2025
    Karen Marie Johnson
    Director · bought 36,224 at $1.04
    $38k
    22% of stake
  • Mar 26, 2025
    Jeremy Castle
    Chief Operating Officer · bought 9,056 at $1.04
    $9k
    11% of stake
  • Mar 26, 2025
    Robert Ross Carter
    Chief Financial Officer · bought 9,056 at $1.04
    $9k
    30% of stake
  • Mar 26, 2025
    Richard A Barasch
    Director · bought 1,358,448 at $1.04
    $1.41M
    326% of stake
  • Nov 26, 2024 – Dec 2, 2024
    Brad Hively
    Director · bought 300,000 at avg $0.17
    $50k
    82% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TOI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Offices & Clinics of Doctors of Medicine

Spot a number that looks wrong? Check it in TOI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TOI

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.